This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's Disorder (TD). The study includes an open-label period followed by…
- Investigator
- Irene A Malaty
- Status
- Accepting Candidates
- Ages
- 6 Years - N/A
- Sexes
- All